European Biotech Acquisition Corp.
Definitive Agreement
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $100M
- Underwriters
- Focus
- Life Sciences, Biotech
- SEC Filings
- 1841258
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive OfficerEduardo Bravo Fernandez de Araoz
- Chief Financial OfficerKoen Sintnicolaas
- DirectorMartijn Kleijwegt
- DirectorMark Wegter
Target Information
Information on the SPAC target for merger.
- Company
- Oculis SA